BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 15933564)

  • 1. Burden of invasive disease caused by Haemophilus influenzae type b in Bamako, Mali: impetus for routine infant immunization with conjugate vaccine.
    Sow SO; Diallo S; Campbell JD; Tapia MD; Keita T; Keita MM; Murray P; Kotloff KL; Levine MM
    Pediatr Infect Dis J; 2005 Jun; 24(6):533-7. PubMed ID: 15933564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of Haemophilus influenzae type b and other invasive diseases in South Korean children.
    Kim JS; Jang YT; Kim JD; Park TH; Park JM; Kilgore PE; Kennedy WA; Park E; Nyambat B; Kim DR; Hwang PH; Kim SJ; Eun SH; Lee HS; Cho JH; Kim YS; Chang SJ; Huang HF; Clemens JD; Ward JI
    Vaccine; 2004 Sep; 22(29-30):3952-62. PubMed ID: 15364444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Haemophilus influenzae type b Conjugate vaccine introduction into routine childhood immunization in Kenya.
    Cowgill KD; Ndiritu M; Nyiro J; Slack MP; Chiphatsi S; Ismail A; Kamau T; Mwangi I; English M; Newton CR; Feikin DR; Scott JA
    JAMA; 2006 Aug; 296(6):671-8. PubMed ID: 16896110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nationwide population-based surveillance of invasive Haemophilus influenzae diseases in children after the introduction of the Haemophilus influenzae type b vaccine in Japan.
    Suga S; Ishiwada N; Sasaki Y; Akeda H; Nishi J; Okada K; Fujieda M; Oda M; Asada K; Nakano T; Saitoh A; Hosoya M; Togashi T; Matsuoka M; Kimura K; Shibayama K
    Vaccine; 2018 Sep; 36(38):5678-5684. PubMed ID: 30122645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal surveillance of Haemophilus influenzae isolates from pediatric patients with meningitis throughout Japan, 2000-2011.
    Ubukata K; Chiba N; Morozumi M; Iwata S; Sunakawa K;
    J Infect Chemother; 2013 Feb; 19(1):34-41. PubMed ID: 22806445
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Slack M; Esposito S; Haas H; Mihalyi A; Nissen M; Mukherjee P; Harrington L
    Expert Rev Vaccines; 2020 Oct; 19(10):903-917. PubMed ID: 32962476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemophilus influenzae meningitis 5 years after introduction of the Haemophilus influenzae type b conjugate vaccine in Brazil.
    Ribeiro GS; Lima JB; Reis JN; Gouveia EL; Cordeiro SM; Lobo TS; Pinheiro RM; Ribeiro CT; Neves AB; Salgado K; Silva HR; Reis MG; Ko AI
    Vaccine; 2007 May; 25(22):4420-8. PubMed ID: 17449150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A polymerase chain reaction for the diagnosis of Haemophilus influenzae type b disease in children and its evaluation during a vaccine trial.
    Hassan-King M; Adegbola R; Baldeh I; Mulholland K; Omosigho C; Oparaugo A; Usen S; Palmer A; Schneider G; Secka O; Weber M; Greenwood B
    Pediatr Infect Dis J; 1998 Apr; 17(4):309-12. PubMed ID: 9576385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemophilus influenzae Type B conjugate vaccine introduction in Mali: impact on disease burden and serologic correlate of protection.
    Sow SO; Tapia MD; Diallo S; Keita MM; Sylla M; Onwuchekwa U; Pasetti MF; Kotloff KL; Levine MM
    Am J Trop Med Hyg; 2009 Jun; 80(6):1033-8. PubMed ID: 19478272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study.
    Adegbola RA; Secka O; Lahai G; Lloyd-Evans N; Njie A; Usen S; Oluwalana C; Obaro S; Weber M; Corrah T; Mulholland K; McAdam K; Greenwood B; Milligan PJ
    Lancet; 2005 Jul 9-15; 366(9480):144-50. PubMed ID: 16005337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the introduction of the Haemophilus influenzae type b conjugate vaccine in an urban setting in southern India.
    Fitzwater SP; Ramachandran P; Kahn GD; Nedunchelian K; Suresh S; Santosham M; Chandran A
    Vaccine; 2019 Mar; 37(12):1608-1613. PubMed ID: 30772069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Prolonged Safety of
    Tripathi N; Mukherjee S
    Infect Disord Drug Targets; 2024; 24(5):e150124225640. PubMed ID: 38231056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nationwide prospective surveillance study in Israel to document pediatric invasive infections, with an emphasis on Haemophilus influenzae type b infections. Israeli Pediatric Bacteremia and Meningitis Group.
    Dagan R; Fraser D; Greif Z; Keller N; Kaufstein M; Shazberg G; Schlesinger M
    Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S198-203. PubMed ID: 9781763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of conjugate Haemophilus influenzae type b (Hib) vaccine introduction in South Africa.
    von Gottberg A; de Gouveia L; Madhi SA; du Plessis M; Quan V; Soma K; Huebner R; Flannery B; Schuchat A; Klugman K
    Bull World Health Organ; 2006 Oct; 84(10):811-8. PubMed ID: 17128361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naturally acquired and conjugate vaccine-induced antibody to Haemophilus influenzae type b (Hib) polysaccharide in Malian children: serological assessment of the Hib immunization program in Mali.
    Hutter J; Pasetti MF; Sanogo D; Tapia MD; Sow SO; Levine MM
    Am J Trop Med Hyg; 2012 Jun; 86(6):1026-31. PubMed ID: 22665612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High incidence of Haemophilus influenzae type b infection in children in Pacific island countries.
    Russell FM; Carapetis JR; Mansoor O; Darcy A; Fakakovi T; Metai A; Potoi NT; Wilson N; Mulholland EK
    Clin Infect Dis; 2003 Dec; 37(12):1593-9. PubMed ID: 14689337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-type b Haemophilus influenzae disease: clinical and epidemiologic characteristics in the Haemophilus influenzae type b vaccine era.
    Heath PT; Booy R; Azzopardi HJ; Slack MP; Fogarty J; Moloney AC; Ramsay ME; Moxon ER
    Pediatr Infect Dis J; 2001 Mar; 20(3):300-5. PubMed ID: 11303834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Haemophilus influenzae type b vaccination on the incidence of invasive Haemophilus influenzae disease in France, 15 years after its introduction.
    Georges S; Lepoutre A; Dabernat H; Levy-Bruhl D
    Epidemiol Infect; 2013 Sep; 141(9):1787-96. PubMed ID: 23425638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-benefit analysis for the use of Haemophilus influenzae type b conjugate vaccine in Santiago, Chile.
    Levine OS; Ortiz E; Contreras R; Lagos R; Vial P; Misraji A; Ferreccio C; Espinoza C; Adlerstein L; Herrera P
    Am J Epidemiol; 1993 Jun; 137(11):1221-8. PubMed ID: 8322763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of haemophilus influenzae type b conjugate vaccine in South Africa and Argentina.
    Martin M; Casellas JM; Madhi SA; Urquhart TJ; Delport SD; Ferrero F; Chamany S; Dayan GH; Rose CE; Levine OS; Klugman KP; Feikin DR
    Pediatr Infect Dis J; 2004 Sep; 23(9):842-7. PubMed ID: 15361724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.